Real World Outcomes in Patients with Advanced Melanoma Treated in Alberta, Canada: A Time-Era Based Analysis

Immune checkpoint and MAP kinase pathway inhibitors can significantly improve long-term survival for patients with melanoma. There is limited real-world data of these regimens’ effectiveness. We retrospectively analyzed 402 patients with unresectable and metastatic melanoma between August 2013 and J...

Descripción completa

Detalles Bibliográficos
Autores principales: Rigo, Rodrigo, Doherty, Jordan, Koczka, Kim, Kong, Shiying, Ding, Philip Q., Cheng, Tina, Cheung, Winson Y., Monzon, Jose G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8534469/
https://www.ncbi.nlm.nih.gov/pubmed/34677256
http://dx.doi.org/10.3390/curroncol28050338

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8534469/
https://www.ncbi.nlm.nih.gov/pubmed/34677256
http://dx.doi.org/10.3390/curroncol28050338

Ejemplares similares